Publications by authors named "R Mathot"

Claim this Profile
P
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.
M R Seefat, D G J Cucchi, L van Boven, N Durdu-Rayman, K Groen, R Mathot

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.
Konrad van der Zwet, Amber D W de Vos, Marjon H Cnossen, Floor C J I Heubel-Moenen, Saskia E M Schols

J Thromb Haemost· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic-guided Dosing of Efanesoctocog Alfa in Haemophilia A Patients.
Jelien den Hollander, Marjon H Cnossen, Ron A A Mathôt

Haemophilia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world population pharmacokinetics of tezacaftor-ivacaftor in children with cystic fibrosis: The SYM-CF study.
Steffie E M Vonk, Suzanne W J Terheggen-Lagro, Eric G Haarman, Hettie M Janssens, Anke-Hilse Maitland-van der Zee

Br J Clin Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can hair concentrations of artemether-lumefantrine be used as a tool to retrospectively determine drug exposure during malaria treatment?
Jenny L Schnyder, Marloes Vos-van der Meer, Reinier M van Hest, Ron Mathot, Patricia Schlagenhauf

New Microbes New Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis